An antibody, specific receptor protein, ligand, nucleic acid sequence (e.g., primer, probe) or similar reagent, which through specific binding or chemical reaction with an intended target, is used to identify or quantify a chemical substance in a biological sp
| Company | Devices | Share |
|---|---|---|
| Cytocell Limited | 1,888 | 41% |
| Immunotech | 696 | 15% |
| Metasystems Probes Gmbh | 527 | 12% |
| Biolegend, Inc. | 390 | 9% |
| Bio Sb, Inc. | 288 | 6% |
| Cell Marque Corporation | 208 | 5% |
| Lumatas Biosystems, Inc. | 119 | 3% |
| Immunalysis Corp | 97 | 2% |
| Miltenyi Biotec B.V. & Co. Kg | 88 | 2% |
| Fort Worth Diagnostics, Llc | 79 | 2% |
| Leica Biosystems Newcastle Ltd | 37 | 1% |
| Invivoscribe, Inc. | 31 | 1% |
Company = labeler of record on GUDID. 29 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MVU | Reagents, Specific, Analyte | 4,358 |
| MVU | Reagents, specific, analyte | 414 |
| KIQ | Kit, Culture, Chromosome | 14 |
| DHB | System, Test, Radioallergosorbent (Rast) Immunological | 1 |
Use these as the dimensions to specify in a tender line.
4,574 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Assay development analyte-specific reagent IVD", from 29 companies. The largest labeler is Cytocell Limited with 41% of records.
MVU (Reagents, Specific, Analyte), MVU (Reagents, specific, analyte), KIQ (Kit, Culture, Chromosome), DHB (System, Test, Radioallergosorbent (Rast) Immunological)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add assay development analyte-specific reagent ivd to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.